Instructions
Title - “What do you call this project/poster?”
Authors - List all authors. See example for formatting here
Synopsis - A synopsis, limited to 800 characters, must be included for each abstract.
Your synopsis should include a brief summary of the problem, methods, results, and conclusions.
The synopsis must only include text, without equations or images, and be without references or
citations to items described in the full abstract. The synopsis should function as a stand-alone overview of your work (and may be published alone in the conference book).
Background - “Why was this study/research performed?” & “How has this problem been studied?” Limit 1600 characters
Methods - "What techniques and measures were used?" Limit 1600 characters
Results - “What was the outcome or principal data and statistical analysis?” Limit 3800 characters
Discussion - “What is the relevance to clinical practice or future research?” Limit 1600 characters.
References: - Citations in the body of the paper - Cite each source in numerical order using Arabic numerals (1, 2, 3…).
- Citations in the reference list - List references numerically in the order by which they were cited in the text.
- Limit 3800 characters.
Poster image - Your poster image must be in JPEG format with a 16:9 ratio. If is the submitters responsibility to ensure the poster is of sufficient high resolution and clarity. Submission that are of insufficient resolution to read clear, or insufficient resolution to clearly see essential data or materials, may be rejected.
Poster presentation video - - Your presentation can be recorded in any way you would like. The video must be recorded by the presenting author. All videos must be hosted on YouTube and the video URL must be submitted with your application. You can choose to make your video public (available via search) or unlisted (available via sharable link only). We recommend you use a recording software such a Zoom or Loom that allows you to include a video of the presenting author.
Disclosure - Works submitted must include an acknowledgment of relevant funding sources of commercial nature and/or consulting or holding of significant equity in a company that could be affected by the results of the study. Other sources of funding should also be acknowledged. e.g. “funded by...” and/or “equity in...”.
If nothing to disclose, state “Nothing to disclose by any author(s).”
Disclosure of funding and/or relationships must not include company logos or other promotional material (text only). Limit 2200 characters.
Limit 2200 characters.
General Information
- Abstracts submitted to, or presented at, other societies or national meetings or to journals may only be submitted for consideration if you have retained copyright authority for any material submitted.
- All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.
- All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
- All submissions must be HIPAA-compliant. Patient confidentiality must be protected. No names, hospital ID numbers or any other identifying information can appear in your presentation.
- In submitting an abstract, all authors retain copyright to the content and agree to grant Neuromodec Education a limited, nonexclusive, royalty-free license to present and reproduce the content online, in print, and in other media or publications associated with its educational programs, and to archive the content online and in other means.
- Abstracts submitted must include data, partial or incomplete data sets (such as data collection interruption by the pandemic) are acceptable. Abstracts that do not present data and only present an “idea” are not acceptable. Abstracts that present new technology or test new technology are acceptable
Reviewer scores and comments are confidential and will not be made available to anyone (including authors) outside of the immediate review process.
- This is no cost to submit an abstract. After Dec 18th, 2020 9 AM (ET) all accepted abstracts will be publicly available through the conference website.
- Accepted abstracts will be made publicly on a permanent basis, and authors may not request abstracts be removed or edited after they are made public.
- All accepted abstracts will be citable through the conference. The conference will provide a “cite as” for each Abstract Homepage.
- Authors may select to have their abstract also published in Brain Stimulation journal. Abstracts selected for this process must contain at least some new analysis, new data, and/or new discussion. Abstracts selected for this process will be subject to secondary review by Brain Stimulation (which will occur after Dec 22, 2020). This will be online only. This will include only the text of the abstract (no poster, images hype-links, comment or other information on the Abstract Home Page). For abstracts that are accepted to Brain Stimulation the conference will automatically update the “cite as” on the Abstract Home page to reflect the Brain Stimulation citation. If you submit your abstract and do not select for this option (before Dec 15th, 2020 at 11:59 ET) then your abstract will not be considered for publication in Brain Stimulation.
Selection Process
Notification
The outcome of each abstract review will be made available on your dashboard under "Status" on Wednesday, December 16th, 2020 by 6 PM (ET)
Review Criteria
- Innovation/Novelty - Advancement of knowledge, and/or improvement of capabilities.
- Quality - All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. Data/outcomes should be substantive and not just implied. When possible, comprehensive statistical analysis should be applied. Images and spectra should be of the highest quality.
- Impact - The method or data in the abstract should aim to advance or change the field or the behavior of clinicians in significant ways.
- Bias - Bias in favor of a particular product or company is grounds for rejection. Use of a particular company’s products or equipment in itself does not represent bias. Likewise, research involving a single method, drug, or device would not constitute bias if it conforms to best practices of study design and analysis. Non data-driven statements of superiority, however, would be considered biased.
- Repetition of Content - Multiple submissions to the conference of the same or nearly the same abstract by the same author(s)/institution(s) is grounds for rejection.
- Clarity - Organization, presentation, structure, readability
Tips:Proofread your abstract before submission. Minimize use of abbreviations. Type in sentence case.
NYC Neuromodulation 2020 Abstract Committee
Adam Woods, University of Florida
Andrea Antal, GWDG
Dylan Edwards, Moss Rehabilitation Research Institute
Ela Plow, Cleveland Clinic
Leigh Charvet, NYU Langone Health
Nigel Gebodh, The City College of New York
Zeinab Esmaeilpour, The City College of New York
Submitting Your Proposal
Due Date
Tuesday, December 15th, 2020 by 11:59 pm, ET
Include
- Authors
- 800-character Synopsis
- All Abstract sections
- Poster Image
- Poster Video (optional)
- Presenting author information
Poster Awards
The Abstract committee will conduct a secondary review of all abstracts after December 18th, 2020, and may ask authors questions through the online comment system. Five posters will be selected for the best poster award.
Authorization
The submitting author verifies, by virtue of submitting the abstract, that all authors agree:
- to the submission of the abstract to the 2020 NYC Neuromodulation Online Conference
- the corresponding author is authorized to submit all materials with permission from all abstract co-authors
- that copyright permissions have been secured (as necessary) for included material
- the abstract includes valid, accurate, and balanced content
